Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. May 1995; 63(5): 1975–1979.
PMCID: PMC173252

Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.


In an effort to relate the protein profile to virulence, proteins from the cellular fractions and from culture supernatants of Streptococcus suis capsular type 2 strains from different geographical origins were compared by using Western blots (immunoblots). The protein profiles of the cellular fractions were similar for the majority of virulent and avirulent isolates studied, with the exception of three virulent Canadian strains for which a 135-kDa protein was not detected. Examination of the culture supernatants revealed the presence of a 135-kDa protein in all strains except the same three virulent Canadian isolates. In addition, a 110-kDa protein was present in 14 of 16 virulent strains and not in avirulent isolates. When injected into mice, the 110-kDa protein induced an immunoglobulin G response and protected against infection with homologous and heterologous virulent strains. Four strains (1330, 0891, TD10, and R75/S2) that were avirulent in the mouse model of infection and four other strains (1591, 999, JL590, and AAH4) that were virulent in the mouse model were injected into pigs. All virulent strains reproduced the disease, and all avirulent strains failed to reproduce the disease (with the exception of transient lameness in one case and fever in another case). The 110-kDa protein therefore appears to be a reliable virulence marker and a good candidate for a subunit vaccine.

Full Text

The Full Text of this article is available as a PDF (451K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Arends JP, Zanen HC. Meningitis caused by Streptococcus suis in humans. Rev Infect Dis. 1988 Jan-Feb;10(1):131–137. [PubMed]
  • Beaudoin M, Higgins R, Harel J, Gottschalk M. Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates. FEMS Microbiol Lett. 1992 Dec 1;78(2-3):111–116. [PubMed]
  • Gottschalk M, Higgins R, Jacques M, Dubreuil D. Production and characterization of two Streptococcus suis capsular type 2 mutants. Vet Microbiol. 1992 Jan;30(1):59–71. [PubMed]
  • Hampson DJ, Trott DJ, Clarke IL, Mwaniki CG, Robertson ID. Population structure of Australian isolates of Streptococcus suis. J Clin Microbiol. 1993 Nov;31(11):2895–2900. [PMC free article] [PubMed]
  • Holt ME, Enright MR, Alexander TJ. Protective effect of sera raised against different fractions of Streptococcus suis type 2. J Comp Pathol. 1990 Jul;103(1):85–94. [PubMed]
  • Iglesias JG, Trujano M, Xu J. Inoculation of pigs with Streptococcus suis type 2 alone or in combination with pseudorabies virus. Am J Vet Res. 1992 Mar;53(3):364–367. [PubMed]
  • Kataoka Y, Haritani M, Mori M, Kishima M, Sugimoto C, Nakazawa M, Yamamoto K. Experimental infections of mice and pigs with Streptococcus suis type 2. J Vet Med Sci. 1991 Dec;53(6):1043–1049. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Smith HE, Vecht U, Gielkens AL, Smits MA. Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) of Streptococcus suis type 2. Infect Immun. 1992 Jun;60(6):2361–2367. [PMC free article] [PubMed]
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. [PMC free article] [PubMed]
  • Vecht U, Arends JP, van der Molen EJ, van Leengoed LA. Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. Am J Vet Res. 1989 Jul;50(7):1037–1043. [PubMed]
  • Vecht U, Wisselink HJ, Anakotta J, Smith HE. Discrimination between virulent and nonvirulent Streptococcus suis type 2 strains by enzyme-linked immunosorbent assay. Vet Microbiol. 1993 Jan;34(1):71–82. [PubMed]
  • Vecht U, Wisselink HJ, Jellema ML, Smith HE. Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun. 1991 Sep;59(9):3156–3162. [PMC free article] [PubMed]
  • Williams AE. Relationship between intracellular survival in macrophages and pathogenicity of Streptococcus suis type 2 isolates. Microb Pathog. 1990 Mar;8(3):189–196. [PubMed]
  • Williams AE, Blakemore WF, Alexander TJ. A murine model of Streptococcus suis type 2 meningitis in the pig. Res Vet Sci. 1988 Nov;45(3):394–399. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...